These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 18569763

  • 1. High rate of smoking abstinence in COPD patients: Smoking cessation by hospitalization.
    Sundblad BM, Larsson K, Nathell L.
    Nicotine Tob Res; 2008 May; 10(5):883-90. PubMed ID: 18569763
    [Abstract] [Full Text] [Related]

  • 2. [Effect of treatment for nicotine dependence in patients with COPD].
    Górecka D, Bednarek M, Nowiński A, Puścińska E, Goljan-Geremek A, Zieliński J.
    Pneumonol Alergol Pol; 2003 May; 71(9-10):411-7. PubMed ID: 15052977
    [Abstract] [Full Text] [Related]

  • 3. Multicomponent individualized smoking cessation intervention for patients with lung disease.
    Jonsdottir H, Jonsdottir R, Geirsdottir T, Sveinsdottir KS, Sigurdardottir T.
    J Adv Nurs; 2004 Dec; 48(6):594-604. PubMed ID: 15548250
    [Abstract] [Full Text] [Related]

  • 4. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [Abstract] [Full Text] [Related]

  • 5. The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia.
    Chou KR, Chen R, Lee JF, Ku CH, Lu RB.
    Int J Nurs Stud; 2004 Mar; 41(3):321-30. PubMed ID: 14967189
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease.
    Wagena EJ, Knipschild PG, Huibers MJ, Wouters EF, van Schayck CP.
    Arch Intern Med; 2005 Oct 24; 165(19):2286-92. PubMed ID: 16246996
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of nicotine addiction. Drug therapy for smoking cessation].
    Pedersen ST, Christensen HR, Døssing M.
    Ugeskr Laeger; 2002 Mar 11; 164(11):1480-4. PubMed ID: 11924470
    [Abstract] [Full Text] [Related]

  • 8. Randomized trial of an intervention to facilitate recycling for relapsed smokers.
    Partin MR, An LC, Nelson DB, Nugent S, Snyder A, Fu SS, Willenbring ML, Joseph AM.
    Am J Prev Med; 2006 Oct 11; 31(4):293-9. PubMed ID: 16979453
    [Abstract] [Full Text] [Related]

  • 9. The effectiveness of smoking cessation groups offered to hospitalised patients with symptoms of exacerbations of chronic obstructive pulmonary disease (COPD).
    Borglykke A, Pisinger C, Jørgensen T, Ibsen H.
    Clin Respir J; 2008 Jul 11; 2(3):158-65. PubMed ID: 20298324
    [Abstract] [Full Text] [Related]

  • 10. Review of bupropion for smoking cessation.
    Richmond R, Zwar N.
    Drug Alcohol Rev; 2003 Jun 11; 22(2):203-20. PubMed ID: 12850907
    [Abstract] [Full Text] [Related]

  • 11. [Success of smoking cessation in patients with chronic obstructive pulmonary disease].
    Aytemur Solak Z, Başoğlu OK, Erdinç E.
    Tuberk Toraks; 2006 Jun 11; 54(1):43-50. PubMed ID: 16615017
    [Abstract] [Full Text] [Related]

  • 12. The place of pharmacotherapy products in smoking cessation.
    Percival J.
    Prof Nurse; 2003 Oct 11; 19(2):113-7. PubMed ID: 14593787
    [Abstract] [Full Text] [Related]

  • 13. [Bupropion SR for weaning from smoking in relapsed smokers: results of an open multicentre trial in Germany].
    Bergmann L, Warncke W, Herschel M.
    Pneumologie; 2004 Mar 11; 58(3):140-6. PubMed ID: 15007784
    [Abstract] [Full Text] [Related]

  • 14. Electronic monitoring of long-term use of the nicotine nasal spray and predictors of success in a smoking cessation program.
    Schneider MP, van Melle G, Uldry C, Huynh-Ba M, Fallab Stubi CL, Iorillo D, Burnier M, Zellweger JP.
    Nicotine Tob Res; 2003 Oct 11; 5(5):719-27. PubMed ID: 14577988
    [Abstract] [Full Text] [Related]

  • 15. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
    Jiménez Ruiz CA, Ramos Pinedo A, Cicero Guerrero A, Mayayo Ulibarri M, Cristobal Fernández M, Lopez Gonzalez G.
    Nicotine Tob Res; 2012 Sep 11; 14(9):1035-9. PubMed ID: 22345320
    [Abstract] [Full Text] [Related]

  • 16. The effect of a minimal contact smoking cessation programme in out-patients with chronic obstructive pulmonary disease: a pre-post-test study.
    Monninkhof E, van der Valk P, van der Palen J, Mulder H, Pieterse M, van Herwaarden C, Zielhuis G.
    Patient Educ Couns; 2004 Mar 11; 52(3):231-6. PubMed ID: 14998591
    [Abstract] [Full Text] [Related]

  • 17. The influence of offering free transdermal nicotine patches on quit rates in a local health department's smoking cessation program.
    Alberg AJ, Stashefsky Margalit R, Burke A, Rasch KA, Stewart N, Kline JA, Ernst PA, Avey A, Hoffman SC.
    Addict Behav; 2004 Dec 11; 29(9):1763-78. PubMed ID: 15530720
    [Abstract] [Full Text] [Related]

  • 18. A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year.
    Grassi MC, Enea D, Ferketich AK, Lu B, Nencini P.
    Nicotine Tob Res; 2009 Sep 11; 11(9):1114-21. PubMed ID: 19654237
    [Abstract] [Full Text] [Related]

  • 19. Smoking cessation advice for patients with chronic periodontitis.
    Nasry HA, Preshaw PM, Stacey F, Heasman L, Swan M, Heasman PA.
    Br Dent J; 2006 Mar 11; 200(5):272-5; discussion 265. PubMed ID: 16528334
    [Abstract] [Full Text] [Related]

  • 20. Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.
    Rose JE, Herskovic JE, Behm FM, Westman EC.
    Nicotine Tob Res; 2009 Sep 11; 11(9):1067-75. PubMed ID: 19567826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.